Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease

OBJECTIVE: Widespread implementation of cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) in clinical settings requires improved accuracy for diagnosis of prodromal disease and for distinguishing AD from non‐AD dementias. Novel and promising CSF biomarkers include neurogranin, a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Clin Transl Neurol
Main Authors: Janelidze, Shorena, Hertze, Joakim, Zetterberg, Henrik, Landqvist Waldö, Maria, Santillo, Alexander, Blennow, Kaj, Hansson, Oskar
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2015
Teme:
Research Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4704480/
https://ncbi.nlm.nih.gov/pubmed/26783546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.266
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki